Extracellular matrix powder protects against bleomycin-induced pulmonary fibrosis

Tissue Engineering - Part A

Volumn 17, Issue 21-22, 2011, Pages 2795-2804

  Manni, Michelle L ^a   Czajka, Caitlin A ^b,c   Oury, Tim D ^a,c   Gilbert, Thomas W ^b,c,d,e  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b University of Pittsburgh   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

^d UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^e CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMISTRY; BIOLOGICAL ORGANS; CELL CULTURE; CELLS; COLLAGEN; MAMMALS; PATHOLOGY; SCAFFOLDS (BIOLOGY); TISSUE;

BLEOMYCINS; BRONCHOALVEOLAR LAVAGE FLUID; C57BL/6 MICE; COLLAGEN DEPOSITION; EPITHELIAL CELL MIGRATION; EPITHELIAL CELLS; EXTRACELLULAR MATRICES; FIBROBLAST PROLIFERATION; IN-VITRO; MATRIX; NORMAL TISSUE; PULMONARY FIBROSIS; REGENERATIVE MEDICINE; SITE-SPECIFIC TISSUE; URINARY BLADDER; WOUND HEALING; WOUND REPAIR;

PEPTIDES;

MUS; SUS;

BLEOMYCIN;

ANIMAL; ARTICLE; BLADDER; C57BL MOUSE; CHEMICALLY INDUCED DISORDER; EXTRACELLULAR MATRIX; LUNG FIBROSIS; LUNG LAVAGE; MALE; METABOLISM; MOUSE; SWINE;

ANIMALS; BLEOMYCIN; BRONCHOALVEOLAR LAVAGE FLUID; EXTRACELLULAR MATRIX; MALE; MICE; MICE, INBRED C57BL; PULMONARY FIBROSIS; SWINE; URINARY BLADDER;

EID: 80155134142     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2011.0023     Document Type: Article

References (48)

1. Meltzer, E.B., and Noble, P.W. Idiopathic pulmonary fibrosis. Orphanet J Rare Dis 3, 8, 2008.
2. Moeller, A., Ask, K., Warburton, D., Gauldie, J., and Kolb, M. The bleomycin animal model: a useful tool to investigate treatment options for idiopathic pulmonary fibrosis?. Int J Biochem Cell Biol 40, 362, 2008.
3. Piguet, P.F., Collart, M.A., Grau, G.E., Sappino, A.P., and Vassalli, P. Requirement of tumour necrosis factor for development of silica-induced pulmonary fibrosis. Nature 344, 245, 1990.
4. Piguet, P.F., Kaufman, S., Barazzone, C., Muller, M., Ryffel, B., and Eugster, H.P. Resistance of TNF/LT alpha double deficient mice to bleomycin-induced fibrosis. Int J Exp Pathol 78, 43, 1997.
5. Zhang, Y., Lee, T.C., Guillemin, B., Yu, M.C., and Rom, W.N. Enhanced IL-1 beta and tumor necrosis factor-alpha release and messenger RNA expression in macrophages from idiopathic pulmonary fibrosis or after asbestos exposure. J Immunol 150, 4188, 1993.
6. Broekelmann, T.J., Limper, A.H., Colby, T.V., and McDonald, J.A. Transforming growth factor beta 1 is present at sites of extracellular matrix gene expression in human pulmonary fibrosis. Proc Natl Acad Sci USA 88, 6642, 1991.
7. Giri, S.N., Hyde, D.M., and Hollinger, M.A. Effect of antibody to transforming growth factor beta on bleomycin induced accumulation of lung collagen in mice. Thorax 48, 959, 1993.
8. Khalil, N., Bereznay, O., Sporn, M., and Greenberg, A.H. Macrophage production of transforming growth factor beta and fibroblast collagen synthesis in chronic pulmonary inflammation. J Exp Med 170, 727, 1989.
9. Korfhagen, T.R., Swantz, R.J., Wert, S.E., McCarty, J.M., Kerlakian, C.B., Glasser, S.W., et al. Respiratory epithelial cell expression of human transforming growth factor-alpha induces lung fibrosis in transgenic mice. J Clin Invest 93, 1691, 1994.
10. Santana, A., Saxena, B., Noble, N.A., Gold, L.I., and Marshall, B.C. Increased expression of transforming growth factor beta isoforms (beta 1, beta 2, beta 3) in bleomycin-induced pulmonary fibrosis. Am J Respir Cell Mol Biol 13, 34, 1995.
11. Brown, B., Lindberg, K., Reing, J., Stolz, D.B., and Badylak, S.F. The basement membrane component of biologic scaffolds derived from extracellular matrix. Tissue Eng 12, 519, 2006.
12. Gilbert, T.W., Stewart-Akers, A.M., Sydeski, J., Nguyen, T.D., Badylak, S.F., and Woo, S.L.-Y. Gene expression by fibroblasts seeded on small intestinal submucosa and subjected to cyclic stretching. Tissue Eng 13, 1313, 2007.
13. Beattie, A.J., Gilbert, T.W., Guyot, J.P., Yates, A.J., and Badylak, S.F. Chemoattraction of progenitor cells by remodeling extracellular matrix scaffolds. Tissue Eng Part A 15, 1119, 2009.
14. Brennan, E.P., Reing, J., Chew, D., Myers-Irvin, J.M., Young, E.J., and Badylak, S.F. Antibacterial activity within degradation products of biological scaffolds composed of extracellular matrix. Tissue Eng 12, 2949, 2006.
15. Brennan, E.P., Tang, X.H., Stewart-Akers, A.M., Gudas, L.J., and Badylak, S.F. Chemoattractant activity of degradation products of fetal and adult skin extracellular matrix for keratinocyte progenitor cells. J Tissue Eng Regen Med 2, 491, 2008.
16. Gilbert, T.W., Stewart-Akers, A.M., Simmons-Byrd, A., and Badylak, S.F. Degradation and remodeling of small intestinal submucosa in canine Achilles tendon repair. J Bone Joint Surg Am 89, 621, 2007.
17. Li, F., Li, W., Johnson, S., Ingram, D., Yoder, M., and Badylak, S.F. Low-molecular-weight peptides derived from extracellular matrix as chemoattractants for primary endothelial cells. Endothelium 11, 199, 2004.
18. Badylak, S.F., and Gilbert, T.W. Immune response to biologic scaffold materials. Semin Immunol 20, 109, 2008.
19. Badylak, S.F., Valentin, J.E., Ravindra, A.K., McCabe, G.P., and Stewart-Akers, A.M. Macrophage phenotype as a determinant of biologic scaffold remodeling. Tissue Eng Part A 14, 1835, 2008.
20. Brown, B.N., Valentin, J.E., Stewart-Akers, A.M., McCabe, G.P., and Badylak, S.F. Macrophage phenotype and remodeling outcomes in response to biologic scaffolds with and without a cellular component. Biomaterials 30, 1482, 2009.
21. Downey, D.M., Harre, J.G., and Pratt, J.W. Functional comparison of staple line reinforcements in lung resection. Ann Thorac Surg 82, 1880, 2006.
22. Downey, D.M., Michel, M., Harre, J.G., and Pratt, J.W. Functional assessment of a new staple line reinforcement in lung resection. J Surg Res 131, 49, 2006.
23. Gilbert, T.W., Nieponice, A., Spievack, A.R., Holcomb, J., Gilbert, S., and Badylak, S.F. Repair of the thoracic wall with an extracellular matrix scaffold in a canine model. J Surg Res 147, 61, 2008.
24. Gilbert, T.W., Gilbert, S., Madden, M., Reynolds, S.D., and Badylak, S.F. Morphologic assessment of extracellular matrix scaffolds for patch tracheoplasty in a canine model. Ann Thorac Surg 86, 967, 2008; discussion 73-74.
25. Gilbert, T.W., Stolz, D.B., Biancaniello, F., Simmons-Byrd, A., and Badylak, S.F. Production and characterization of ECM powder: implications for tissue engineering applications. Biomaterials 26, 1431, 2005.
26. Fattman, C.L., Chu, C.T., Kulich, S.M., Enghild, J.J., and Oury, T.D. Altered expression of extracellular superoxide dismutase in mouse lung after bleomycin treatment. Free Radic Biol Med 31, 1198, 2001.
27. Ramsgaard, L., Englert, J.M., Tobolewski, J., Tomai, L., Fattman, C.L., Leme, A.S., et al. The role of the receptor for advanced glycation end-products in a murine model of silicosis. PLoS One 5, e9604, 2010.
28. Englert, J.M., Hanford, L.E., Kaminski, N., Tobolewski, J.M., Tan, R.J., Fattman, C.L., et al. A role for the receptor for advanced glycation end products in idiopathic pulmonary fibrosis. Am J Pathol 172, 583, 2008.
29. Fattman, C.L., Tan, R.J., Tobolewski, J.M., and Oury, T.D. Increased sensitivity to asbestos-induced lung injury in mice lacking extracellular superoxide dismutase. Free Radic Biol Med 40, 601, 2006.
30. Gilbert, T.W., Agrawal, V., Gilbert, M.R., Povirk, K.M., Badylak, S.F., and Rosen, C.A. Liver-derived extracellular matrix as a biologic scaffold for acute vocal fold repair in a canine model. Laryngoscope 119, 1856, 2009.
31. Kliment, C.R., Englert, J.M., Gochuico, B.R., Yu, G., Kaminski, N., Rosas, I., et al. Oxidative stress alters syndecan-1 distribution in lungs with pulmonary fibrosis. J Biol Chem 284, 3537, 2009.
32. Liang, C.C., Park, A.Y., and Guan, J.L. In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro. Nat Protoc 2, 329, 2007.
33. Lazo, J.S., and Pham, E.T. Pulmonary fate of 3H bleomycin A2 in mice. J Pharmacol Exp Ther 228, 13, 1984.
34. Vracko, R. Basal lamina scaffold-anatomy and significance for maintenance of orderly tissue structure. Am J Pathol 77, 314, 1974.
35. Reing, J.E., Zhang, L., Myers-Irvin, J., Cordero, K.E., Freytes, D.O., Heber-Katz, E., et al. Degradation products of extracellular matrix affect cell migration and proliferation. Tissue Eng Part A 15, 605, 2009.
36. Gao, F., Koenitzer, J.R., Tobolewski, J.M., Jiang, D., Liang, J., Noble, P.W., et al. Extracellular superoxide dismutase inhibits inflammation by preventing oxidative fragmentation of hyaluronan. J Biol Chem 283, 6058, 2008.
37. Kliment, C.R., Tobolewski, J.M., Manni, M.L., Tan, R.J., Enghild, J., and Oury, T.D. Extracellular superoxide dismutase protects against matrix degradation of heparan sulfate in the lung. Antioxid Redox Signal 10, 261, 2008.
38. Petersen, S.V., Oury, T.D., Ostergaard, L., Valnickova, Z., Wegrzyn, J., Thogersen, I.B., et al. Extracellular superoxide dismutase (EC-SOD) binds to type i collagen and protects against oxidative fragmentation. J Biol Chem 279, 13705, 2004.
39. Badylak, S.F., Freytes, D.O., and Gilbert, T.W. Extracellular matrix as a biological scaffold material: structure and function. Acta Biomater 5, 1, 2009.
40. Hancock, A., Armstrong, L., Gama, R., and Millar, A. Production of interleukin 13 by alveolar macrophages from normal and fibrotic lung. Am J Respir Cell Mol Biol 18, 60, 1998.
41. Murray, L.A., Rosada, R., Moreira, A.P., Joshi, A., Kramer, M.S., Hesson, D.P., et al. Serum amyloid P therapeutically attenuates murine bleomycin-induced pulmonary fibrosis via its effects on macrophages. PLoS One 5, e9683, 2010.
42. Cortiella, J., Niles, J., Cantu, A., Brettler, A., Pham, A., Vargas, G., et al. Influence of acellular natural lung matrix on murine embryonic stem cell differentiation and tissue formation. Tissue Eng Part A 16, 2565, 2010.
43. Jungebluth, P., Go, T., Asnaghi, A., Bellini, S., Martorell, J., Calore, C., et al. Structural and morphologic evaluation of a novel detergent-enzymatic tissue-engineered tracheal tubular matrix. J Thorac Cardiovasc Surg 138, 586, 2009.
44. Macchiarini, P., Jungebluth, P., Go, T., Asnaghi, M.A., Rees, L.E., Cogan, T.A., et al. Clinical transplantation of a tissueengineered airway. Lancet 372, 2023, 2008.
45. Ott, H.C., Clippinger, B., Conrad, C., Schuetz, C., Pomerantseva, I., Ikonomou, L., et al. Regeneration and orthotopic transplantation of a bioartificial lung. Nat Med 16, 927, 2010.
46. Petersen, T.H., Calle, E.A., Zhao, L., Lee, E.J., Gui, L., Raredon, M.B., et al. Tissue-engineered lungs for in vivo implantation. Science 329, 538, 2010.
47. Price, A.P., England, K.A., Matson, A.M., Blazar, B.R., and Panoskaltsis-Mortari, A. Development of a decellularized lung bioreactor system for bioengineering the lung: the matrix reloaded. Tissue Eng Part A 16, 2581, 2010.
48. Remlinger, N.T., Czajka, C.A., Juhas, M.E., Vorp, D.A., Stolz, D.B., Badylak, S.F., et al. Hydrated xenogeneic decellularized tracheal matrix as a scaffold for tracheal reconstruction. Biomaterials 31, 3520, 2010.